FDA Recall Open, Classified

Contour next GEN Blood Glucose Monitoring System

Recall: Z-2211-2023 · Initiated May 19, 2023

Recall

Recall Number
Z-2211-2023
Event Number
92536
Firm
Ascensia Diabetes Care US, Inc.
FEI Number
1810909
Product Code
NBW
Status
Open, Classified
Root Cause
Process control
Initiated
May 19, 2023
Posted
July 20, 2023
Address
100 Summit Lake Dr, Valhalla, NY, 10595-1339

Description

Contour next GEN Blood Glucose Monitoring System

Reason

Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the meter kit and had incorrect factory-set unit of measure where the meters display glucose results in mmol/L rather than mg/dL. The standard unit of measurement for the United States is mg/dL. If a consumer does not notice the incorrect unit of measurement, it is possible that the meters glucose measurement will be read as a lower blood glucose measurement than expected, and this may result in the patients glucose level remaining high, which can potentially lead to an injury requiring immediate medical intervention.

Action

The firm sent recall notifications to customers dated 06/21/2023. Customers are asked to check their personal meters and entities are asked to check their stock to identify any affected devices. If you are aware of any patients or customers downstream who have received a recalled device make them aware of this recall. Anyone with a recalled unit can contact the firm at 1-800-348-8100 or by email at [email protected] to initiate return and replacement of devices. Response Forms were provided for customers to return via email to [email protected].

Distribution

Domestic: CA, CO, FL, IN, MO, NJ, NY, OH, RI, SC, TN, TX, & VA.

Quantity

2,888 units